Host:  Dr. Ryan Thomas
Guest: Dr. Christina Barreda

Contact Information

Email:
Tidal Volume

Twitter Accounts:
Ryan Thomas, MD
 @MSUPedsPulm

Christina Barreda, MD
 @CB_Barreda

ATS Peds:
 @ATSPeds

References

1. Finkle RS et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.  Neuromuscul Disord. 2018 Mar;28(3):197-207
2. Schroth MK. Special Considerations in the Respiratory Management of Spinal Muscular Atrophy Pediatrics May 2009, 123 (Supplement 4) S245-S249
3. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997;112(4):1024–1028.
4. Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type 1. A noninvasive respiratory management approach. Chest 2000;117(4):1100–1105.
5. Bach JR, Baird JS, Plosky D, Navado J, Weaver B. Spinal muscular atrophy type 1: management and outcomes. Pediatr Pulmonol 2002;34(1):16–22.
6. Miske LJ et al. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest. 2004 Apr;125(4):1406-12.
7. Morrow B et al.  Mechanical insufflation-exsufflation for people with neuromuscular disorders. Cochrane Database Syst Rev. 2013 Dec 30;(12):CD010044.